UnitedHealth Group Incorporated
Bear Case (25th pct.)
-51.0% vs price
Base Case (Median)
-42.9% vs price
Bull Case (75th pct.)
-30.5% vs price
◇ = Current price | |Bear |Base | Bull
| Method | Est. Value | vs Price | Weight |
|---|---|---|---|
| DCF (Discounted Cash Flow) | $195.54 | -52.0% | High (40%) |
| PE Comparable | $293.46 | -28.0% | Medium (25%) |
| Graham Number | $175.52 | -56.9% | Medium (40%) |
| EV/EBITDA | $253.41 | -37.8% | Medium (20%) |
| EV/FCF | $432.22 | 6.0% | Medium (20%) |
| Earnings Power Value | $211.75 | -48.1% | Medium (50%) |
Based on 6 out of 8 methods, UNH appears overvalued at the current price of $407.65. The base case fair value of $232.58 implies 42.9% downside.
Bear/base/bull cases represent the 25th, 50th, and 75th percentile of available method estimates. This is not financial advice. Valuation is inherently uncertain.